BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 28042609)

  • 1. Hepatitis B virus molecular biology and pathogenesis.
    Lamontagne RJ; Bagga S; Bouchard MJ
    Hepatoma Res; 2016; 2():163-186. PubMed ID: 28042609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of apoptotic signaling by the hepatitis B virus X protein.
    Rawat S; Clippinger AJ; Bouchard MJ
    Viruses; 2012 Nov; 4(11):2945-72. PubMed ID: 23202511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival.
    Rawat S; Bouchard MJ
    J Virol; 2015 Jan; 89(2):999-1012. PubMed ID: 25355887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.
    Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma.
    Robinson WS
    Annu Rev Med; 1994; 45():297-323. PubMed ID: 8198385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepadnaviruses, their infections and hepatocellular carcinoma.
    Bukhari SS; Tsiquaye KN
    J Pak Med Assoc; 1990 Dec; 40(12):300-6. PubMed ID: 2178194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.
    Sartorius K; An P; Winkler C; Chuturgoon A; Li X; Makarova J; Kramvis A
    Front Immunol; 2021; 12():661204. PubMed ID: 33995383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus modulates store-operated calcium entry to enhance viral replication in primary hepatocytes.
    Casciano JC; Duchemin NJ; Lamontagne RJ; Steel LF; Bouchard MJ
    PLoS One; 2017; 12(2):e0168328. PubMed ID: 28151934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication.
    Gearhart TL; Bouchard MJ
    J Virol; 2010 Mar; 84(6):2675-86. PubMed ID: 20053744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Expression of DNA Damage Repair Genes High Mobility Group Box1 and Poly(ADP-ribose) Polymerase1 in Inactive Carriers of Hepatitis B Virus Infection-A Possible Stage of Viral Integration.
    Mukherjee RM; Shravanti GV; Jakkampudi A; Kota R; Jangala AL; Reddy PB; Rao PN; Gupta R; Reddy DN
    J Clin Exp Hepatol; 2013 Jun; 3(2):89-95. PubMed ID: 25755481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
    Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
    Lamontagne J; Steel LF; Bouchard MJ
    World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of the hepatitis B virus for clinicians.
    Datta S; Chatterjee S; Veer V; Chakravarty R
    J Clin Exp Hepatol; 2012 Dec; 2(4):353-65. PubMed ID: 25755457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma.
    Robinson WS; Klote L; Aoki N
    J Med Virol; 1990 May; 31(1):18-32. PubMed ID: 2165515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Rizzo GEM; Cabibbo G; Craxì A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral and cellular determinants involved in hepadnaviral entry.
    Glebe D; Urban S
    World J Gastroenterol; 2007 Jan; 13(1):22-38. PubMed ID: 17206752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Zeisel MB; Guerrieri F; Levrero M
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33923385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates.
    Agustiningsih A; Rasyak MR; Turyadi ; Jayanti S; Sukowati C
    Explor Target Antitumor Ther; 2024; 5(1):120-134. PubMed ID: 38464387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.
    Freitas N; Lukash T; Gunewardena S; Chappell B; Slagle BL; Gudima SO
    J Virol; 2018 May; 92(10):. PubMed ID: 29491161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.